Share

US future stocks up ahead of jobless data

New York - US stock index futures edged higher on Thursday, with investors reluctant to make big bets following a sharp rally in the previous session and amid signs of weak conditions in Europe.

Trading is likely to continue being driven by overseas issues, with the latest data out of Europe showing the euro zone's economy ground to a halt in the second quarter. Investors are also monitoring ongoing violence in Iraq, and the conflict between Ukraine and Russia.

Walmart Stores reported flat same-store sales for the second-quarter and cut its full-year profit outlook. After falling more than 1% in premarket trading, shares of the Dow component rose slightly.

Cisco Systems fell 1.3% to $24.87 in premarket trading. The company gave a tepid outlook a day earlier for its current quarter and announced massive job cuts even as the Dow component's revenue beat expectations.

Walmart and Cisco are the latest major names to issue cautious outlooks. On Wednesday, Macy's cut its full-year same-store sales outlook while Deere & Co cut its profit view.

S&P 500 e-mini futures rose 3 points and were above fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract.

Dow Jones industrial average e-mini futures rose 24 points and Nasdaq 100 e-mini futures added 5.75 points.

Wall Street rallied on Wednesday, with the Dow Jones industrial average returning to positive territory for the year. The S&P 500 is about 2.1% off a late-July record close.

In upcoming US economic data, weekly jobless claims are seen rising by 6 000 to 295 000. The report will be released at 14:30 along with import and export prices for July.

The chief executive of NewLink Genetics, which licensed an Ebola vaccine developed by Canadian government scientists, late Wednesday told Reuters it has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer.

The US Food and Drug Administration late on Wednesday said it had approved a new insomnia drug made by Merck & Co.


We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Rand - Dollar
18.88
+0.3%
Rand - Pound
23.85
+0.2%
Rand - Euro
20.37
+0.3%
Rand - Aus dollar
12.31
+0.3%
Rand - Yen
0.12
+0.3%
Platinum
908.05
0.0%
Palladium
1,014.94
0.0%
Gold
2,232.75
-0.0%
Silver
24.95
-0.1%
Brent Crude
87.00
+1.8%
Top 40
68,346
0.0%
All Share
74,536
0.0%
Resource 10
57,251
0.0%
Industrial 25
103,936
0.0%
Financial 15
16,502
0.0%
All JSE data delayed by at least 15 minutes Iress logo
Company Snapshot
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE
Government tenders

Find public sector tender opportunities in South Africa here.

Government tenders
This portal provides access to information on all tenders made by all public sector organisations in all spheres of government.
Browse tenders